Characteristic | NT (%) | NUC (%) | NC (%) | Odds ratio (95% CI) | P value | |
---|---|---|---|---|---|---|
637 | 466 (73.2) | 171 (26.8) | ||||
Gender | Male | 403 (63.3) | 282 (60.5) | 121 (70.8) | 1.58 (1.082-2.305) | 0.018 |
Female | 234 (36.7) | 184 (39.5) | 50 (29.2) | Reference | 1.000 | |
Age (years) | ≤30 | 126 (19.8) | 106 (27) | 20 (11.7) | Reference | |
31-40 | 136 (21.4) | 97 (29.2) | 39 (22.8) | 2.13 (1.163-3.904) | 0.014 | |
41-50 | 144 (22.6) | 109 (30.9) | 35 (20.5) | 1.70 (0.924-3.135) | 0.088 | |
51-60 | 231 (36.3) | 154 (49.6) | 77 (45.0) | 2.65 (1.528-4.596) | 0.001 | |
Co-morbid conditions | ||||||
Malignancy | 60 (9.4%) | 32 (6.9) | 28 (16.4) | 2.66 (1.546-4.563) | <0.0001 | |
Prior neurologic damage | 125 (19.6%) | 57 (12.2) | 68 (39.8) | 4.74 (3.134-7.160) | <0.0001 | |
Chronic renal failure | 26 (4.1%) | 15 (3.2) | 11 (6.4) | 2.07 (0.930-4.594) | 0.075 | |
Heart disease | 56 (8.8%) | 34 (7.3) | 22 (12.9) | 1.88 (1.063-3.310) | 0.030 | |
Lung disease* | 193 (30.3%) | 128 (27.5) | 65 (38) | 1.61 (1.115-2.337) | 0.011 | |
Asthma | 41 (6.4%) | 35 (7.5) | 6 (3.5) | 0.45 (0.185-1.084) | 0.075 | |
Chronic obstructive lung disease | 77 (12.1%) | 50 (10.7) | 27 (15.8) | 1.56 (0.941-2.585) | 0.084 | |
Lung malignancy | 37 (5.8%) | 20 (4.3) | 17 (9.9) | 2.46 (1.257-4.820) | 0.009 | |
Post chest radiation | 31 (4.9%) | 14 (3) | 17 (9.9) | 2.96 (1.074-8.146) | 0.036 | |
Immune deficiency | 156 (24.5%) | 98 )21) | 58 (33.9) | 1.93 (1.309-2.839) | 0.001 | |
Hematologic malignancy | 45 (7.1%) | 30 (6.4) | 15 (8.8) | 2.38 (0.944-5.982) | 0.066 | |
Corticosteroid therapy | 76 (11.9%) | 44 (9.4) | 32 (18.7) | 2.21 (1.347-3.619) | 0.002 | |
Nursing institution | 52 (8.2%) | 21 (4.5) | 31 (18.1) | 4.69 (2.612-8.427) | <0.0001 | |
SBP on admission (mmHg) | 137.3 ± 32.1 | 137.9 ± 36.1 | 136.6 ± 29.0 | 1.009 (0.942-1.082) | NS | |
DBP on admission (mmHg) | 77.4 ± 16.1 | 77.8 ± 18.3 | 76.9 ± 12.6 | 1.011(0.945-1.081) | NS | |
Heart rate on admission (min-1) | 86.7 ± 20.2 | 86.8 ± 20.6 | 86.7 ± 20.1 | 0.998 (0.926-1.077) | NS | |
Laboratory parameters | ||||||
BUN > 10.7 mmol/L | 65 (10.2%) | 35 (7.5) | 30 (17.5) | 2.62 (1.552-4.422) | <0.0001 | |
Creatinine >114 μmol/L | 88 (13.8%) | 54 (11.6) | 34 (19.9) | 1.89 (1.183-3.031) | 0.008 | |
Hemoglobin <110 g/L | 113 (17.7%) | 68 (14.6) | 45 (26.3) | 2.11 (1.375-3.229) | 0.001 | |
Hematocrit <30 mg/dl | 56 (8.8%) | 31 (6.7) | 25 (14.6) | 2.42 (1.383-4.233) | 0.002 | |
Glucose >13.8 mmol/L | 39 (6.1%) | 24 (5.2) | 15 (8.8%) | 1.77 (0.903-3.454) | 0.096 | |
WBC <4 or >12 × 109/L | 347 (54.5%) | 238 (51.1) | 109 (63.7) | 1.68 (1.174-2.416) | 0.005 | |
RDW >14.5% | 218 (34.2%) | 123 (26.4) | 95 (55.6) | 3.49 (2.419-5.023) | <0.0001 |